Effects of different Fasciola hepatica recombinant proteins on the biochemical and serological responses of experimentally infected sheep

In the DELIVER (Full project title: Design of effective and sustainable control strategies for liver fluke in Europe) project the objective was to analyze 3 recombinant antigens for their capacity to induce a satisfied immune response in sheep, to challenge the animals with metacercariae of Fasciola hepatica, and to observe their immune response and protection from the parasitosis. The animals were treated initially with metacercariae and every second week blood was taken for liver enzyme estimation of lactate dehydrogenase (LDH), gamma-glutamyl transferase (gGT), and antibody response. After the 3rd month of infection all the animals developed parasitosis, although to different extents. Differential observations of the blood showed a rise in eosinophils after the 3rd month (typical by parasitoses) and specific reactions of the other white blood cells. The LDH and (gGT liver enzymes showed a slight fluctuation in comparison with the initial values. The antibody (immunoglobulin G1) formations against the different antigens (made by enzyme-linked immunosorbent assay) were typical as well, but not strong enough to protect the animals from the disease. The immune response was mostly pronounced against the cathepsin L1 antigen, with the highest values after 5–6 months. It turned out that the chosen adjuvant was successful too, because of the high response to it alone. The differential count of the blood cells showed a rise in the eosinophils. The liver enzymes were not typical for this disease. The results gave strong suggestions of how to operate further and what kind of corrections should be made.

Anahtar Kelimeler:

Key words: Fasciola hepatica, TPx and CL1 antibodies, blood smears, LDH, (gGT

Effects of different Fasciola hepatica recombinant proteins on the biochemical and serological responses of experimentally infected sheep

Keywords:

Key words: Fasciola hepatica, TPx and CL1 antibodies, blood smears, LDH, (gGT,

PDF

___

Salimi-Bejestani, M.R., McGarry, J.W., Felsted, S., Ortiz, P., Akca, A., Williams, D.J.L.: Development of an antibodydetection ELISA for Fasciola hepatica and its evaluation against a commercially available test. Res. Vet. Sci., 2005; 78: 177–181.
Cornelissen, J.B.W., Gaasenbeek, C.P.H., Boersma, W., Borgsteede, F.H., van Milligen, F.J.: Use of a pre-selected epitope of cathepsin-L1 in a highly specific peptide-based immunoassay for the diagnosis of Fasciola hepatica infections in cattle. Intern. J. Parasitol., 1999; 29: 685–696.
Dalton, J.P., Neill, S.O., Stack, C., Collins, P., Walshe, A., Sekiya, M., Doyle, S., Mulcahy, G., Hoyle, D., Khaznadji, E., Moiré N., Brennan, G., Mousley, A., Kreshchenko, N., Maule, A.G., Donnelly, S.M.: Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines. Intern. J. Parasitol., 2003; 33: 1173–1181.
Mulcahy, G., Dalton, J.P.: Cathepsin L proteinases as vaccines against infection with Fasciola hepatica (liver fluke) in ruminants. Res. Vet. Sci., 2001; 70: 83–86.
Harmsen, M.M., Cornelissen, B.W.J., Buijs, H.E.C.M., Boersma, W.J.A., Jeurissen, S.H.M., van Milligen, F.J.: Identification of a novel Fasciola hepatica cathepsin L protease containing protective epitopes within the propeptide. Intern. J. Parasitol., 2004; 34: 675–682.
Bossaert, K., Farnir, F., Leclipteux, T., Protz, M., Lonneux, J.F., Losson, B.: Humoral immune response in calves to single-dose, trickle and challenge infections with Fasciola hepatica. Vet. Parasitol., 2000; 87: 103–123.
Phiri, I.K., Phiri, A.M., Harrison, L.J.S.: Serum antibody isotype responses of Fasciola-infected sheep and cattle to excretory and secretory products of Fasciola species. Vet. Parasitol., 2006; 141: 234–242.
Wolstenholme, A.J., Fairweather, I., Prichard, R., von SamsonHimmelstjerna, G., Sangster, N.C.: Drug resistance in veterinary helminths. Trends Parasitol., 2004; 20: 469–476.
Dalsgaard, K.: Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in foodand-mouth disease vaccines. Arch. Ges. Virusforsch., 1974; 44: 243–254.
Kensil, C.R.: Saponins as vaccine adjuvants. Crit. Rev. Ther. Drug Carrier Syst., 1996; 13: 1–55.
Haçarız, O., Sayers, G., McCullough, M., Garrett, M., O’Donovan, J., Mulcahy, G.: The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep. Vaccine, 2009; 27: 45–50.
Donnelly, S., O’Neill, S.M., Sekiya, M., Mulcahy, G., Dalton, J.P.: Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Infect. Immun., 2005; 73: 166–173.
Yang, Q., Mao, W.H., Ferre, I., Bayoân, J.E., Mao, X.Z., González-Gallego, J.: Plasma aspartate aminotransferase (AST), glutamate dehydrogenase (GLDH) and gammaglutamyl transpeptidase (GGT) activities in water buffaloes with experimental subclinical fasciolosis. Vet. Parasitol., 1998; 78: 129–136.
Pulendran, B., Ahmed, R.: Translating innate immunity into immunological memory: implications for vaccine development. Cell, 2006; 124: 849–863.
Serradell, M.C., Guasconi, L., Cervi, L., Chiapello, L.S., Masih, D.T.: Excretory-secretory products from Fasciola hepatica induce eosinophil apoptosis by a caspase-dependent mechanism. Vet. Immunol. Immunopathol., 2007; 117: 197– 20
Zhang, W.Y., Moreau, E., Hope, J.C., Howard, C.J., Huang, W.Y., Chauvin, A.: Fasciola hepatica and Fasciola gigantica: comparison of cellular response to experimental infection in sheep. Exp. Parasitol., 2005; 111: 154–159.